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Abstract
SELDI-TOF mass spectrometer’s compact size and automated, high throughput design have been attractive to clinical
researchers, and the platform has seen steady-use in biomarker studies. Despite new algorithms and preprocessing
pipelines that have been developed to address reproducibility issues, visual inspection of the results of SELDI spectra
preprocessing by the best algorithms still shows miscalled peaks and systematic sources of error. This suggests that there
continues to be problems with SELDI preprocessing. In this work, we study the preprocessing of SELDI in detail and
introduce improvements. While many algorithms, including the vendor supplied software, can identify peak clusters of
specific mass (or m/z) in groups of spectra with high specificity and low false discover rate (FDR), the algorithms tend to
underperform estimating the exact prevalence and intensity of peaks in those clusters. Thus group differences that at first
appear very strong are shown, after careful and laborious hand inspection of the spectra, to be less than significant. Here we
introduce a wavelet/neural network based algorithm which mimics what a team of expert, human users would call for peaks
in each of several hundred spectra in a typical SELDI clinical study. The wavelet denoising part of the algorithm optimally
smoothes the signal in each spectrum according to an improved suite of signal processing algorithms previously reported
(the LibSELDI toolbox under development). The neural network part of the algorithm combines those results with the raw
signal and a training dataset of expertly called peaks, to call peaks in a test set of spectra with approximately 95% accuracy.
The new method was applied to data collected from a study of cervical mucus for the early detection of cervical cancer in
HPV infected women. The method shows promise in addressing the ongoing SELDI reproducibility issues.
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Introduction
The data analysis pipeline following a SELDI study involves 1)
preprocessing to produce quantified peak clusters, 2) manually
validating peak clusters as a QC step, and 3) group analysis to find
differences between cases and controls. The methodology for
preprocessing SELDI involves multiple algorithmic steps, and has
been reviewed in [1]. In particular, the goal of preprocessing is to
detect peaks in individual spectra corresponding to proteins and to
produce estimates of peak areas/concentrations while minimizing
the effects of noise and artifacts. Validation and QC of the
preprocessing steps is generally done manually and can be time-
consuming. In addition, visual interpretation is not always
objective and it is not uncommon for experts to have trouble
reaching a consensus about the validity of a preprocessing result.
However, this step is essential in order to reduce the chance that
false positive and false negative peaks may bias the group
comparison results. In a group analysis, peaks detected across
multiple spectra are associated together to form peak clusters
estimated to be from the same analyte (present/absent across
samples, with varying peak area/concentration). Statistical tech-
niques such as t-tests and Mann-Whitney U-tests are used to find
peaks that are significantly different between groups. Out of these
three major components in the SELDI clinical data analysis
pipeline, the manual validation step can be especially laborious
especially on heterogeneous clinical data that may contain
subtypes. This ultimately limits the size of study feasible with
SELDI.
In order to facilitate more accurate SELDI studies with larger
sample sizes, we introduce a neural network model to improve the
automation of the validation step along with major improvements
to the LibSELDI preprocessing approach. The neural network is
trained on approximately 4200 expert annotated peaks. In this
way, the neural network mimics the validation behavior of our in-
house scientists in a more automated and objective fashion. The
algorithm improvements to LibSELDI include 1) a 6506speed up
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of the algorithm, 2) improved denoising to reduce artifacts, and 3)
quantitation. These algorithm improvements are demonstrated on
a pooled-sample dataset. Finally, the improved LibSELDI is
combined with the neural network and tested on a pilot clinical
dataset consisting of samples from two different stages of cervical
neoplasia. We compare the results of the LibSELDI/neural
network approach to the standard Ciphergen Express analytical
software on both the QC samples and the clinical samples.
Methods
Ethics Statement
This research was approved by the Centers for Disease Control
and Prevention’s Institutional Review Board. Informed consent
was obtained in writing from participants in the study.
Cervical mucous was collected from women enrolled as part of
an ongoing study of cervical neoplasia [2]. Briefly, participants
were non-pregnant, HIV-negative women, aged between 18–69
years, attending colposcopy clinics at urban public hospitals in
Atlanta, Georgia, and Detroit, Michigan between December 2000
and June 2004. As previously described, at the time of colposcopy
two Weck-CelH sponges (Xomed Surgical Products, Jacksonville,
FL) were placed, one at a time, into the opening of the cervical
canal that leads to the cavity of the uterus (cervical os) to absorb
cervical secretions [3]. The wicks were immediately placed on dry
ice and stored at 280uC until processed. Preparation of the pooled
QC sample has been previously described [3,4]. Forty Weck-CelH
sponges with no visual blood contamination from 25 randomly
selected subjects were extracted using M-PERH buffer (Thermo
Fisher Scientific, Rockford, IL) containing 0.15M NaCl and 16
protease inhibitor (Roche, Indianapolis, IN). The extracts were
combined, aliquoted and stored at 280uC until assayed. Total
protein content was measured using the Coomasie PlusTM kit
(Thermo Fisher Scientific) as per the manufacturer’s protocol. For
the pilot clinical analysis we selected 16 non-dysplastic cervical
mucosa controls (CIN0) and 8 cervical intraepithelial neoplasia
grade III cases (CIN3) consisting of post-menopausal women
matched for age and race, so as to minimize the confounding
effects of varied stages of the menstrual cycle on protein profiles.
The Protein Biological System II-cTM mass spectrometer, with
Protein Chip software (version 3.2) (Ciphergen Biosystems,
Fremont, CA) was used to perform SELDI-TOF MS as described
previously [5]. Protein chip surface preparation, sample applica-
tion, wash, and application of matrix was automated using the
BiomekH 2000 laboratory automation workstation (Beckman
Coulter Inc., Fullerton, CA) as per manufacturer’s instructions
(Ciphergen). The All-in-one protein standard (Ciphergen) was run
weekly on the NP-20 (normal phase) chip surface (Ciphergen) to
be used for external mass calibration. The QC sample was
included as one spot on at least one chip in each run. The
prepared weak cation exchanger chips (CM10) evaluated were
incubated with the sample for 1 h at room temperature (24uC62)
and washed three times at 5 min intervals with the CM10 low
stringency binding buffer, followed by a final wash with ddH2O. In
the case of NP-20 arrays, the surface was prepared with 3 mL
ddH2O, and ddH2O was used for all washing steps. Chips were
air-dried 30 min prior to the application of sinnapinic acid (SPA)
matrix. The chips were analyzed on the SELDI-TOF instrument
within 4 h of application of the matrix. The previously optimized
instrument settings were used here [5]. Data collection was set to
150 kDa optimized for m/z between 3–30 kDa for the low mass
range. The laser intensity was set at 185 with a detector sensitivity
of 8 and number of shots averaged at 180 per spot for each sample.
Two warming shots were fired at each position with the selected
laser intensity +10. These were not included in the data collection.
Data was exported to Ciphergen Express Client (CE, version 3.5)
for further analysis. Data collection from start to finish took
2 weeks.
CE was used to preprocess the spectra following a modification
of the standard operating procedure that has been developed in
house and previously described [6]. Briefly, baseline correction,
external calibration using protein standards, normalization using
total ion current, and mass alignment were applied to all spectra.
Peak detection was performed on this pre-processed data. Peaks
from 3–30 kDa were detected by centroid mass, minimum percent
threshold set to 10%, estimated peaks, and a mass window of
0.3%. Two different signal to noise settings were used for peak
detection 1) First pass (S/N) = 5, valley depth = 3, Second pass
(S/N) = 3, valley depth = 2; 2) First pass (S/N) = 3, valley depth
= 2, no second pass. Group differences between Cin0 and Cin3
were estimated using the p-value wizard in CE. Significance of the
median peak intensities between the 2 groups was calculated using
the Mann-Whitney test as described in the Protein Chip Data
Manager Software 3.5 Operation Manual.
Orthogonal wavelet transforms, while having excellent denois-
ing properties in the mean-squared error sense, can sometimes
produce artifacts. These artifacts appear in the data as localized
ringing in the vicinity of high frequency components/discontinu-
ities (the pseudo-Gibbs effect) and reconstruction errors containing
imprints of the particular wavelet basis used with the transform.
To address these issues, Coifman and Donoho introduced the
concept of cycle-spinning [7]. Let denote the vector of raw
intensities measured from a SELDI experiment, and let and be the
circulant-shift operator and the wavelet-denoising operator,
respectively. The ‘‘Cycle-Spinning’’ wavelet transform is defined
by Coifman and Donoho as
T(x;D)~Aved[DS{d(T(Sd(x))), ð1Þ
where D is a set of signal shifts. In other words, this framework is a
shift-denoise-unshift-average approach [7]. Coifman and Donoho
have shown that this approach suppresses the energy in artifacts.
The cycle-spinning wavelet transform is also equivalent to the
undecimated and translation-invariant wavelet transforms.
Coombes et al. [8] have previously introduced the undecimated
wavelet transform for application to SELDI data. Since this is a
general framework and T can represent any wavelet denoising
operator, we extended the quadratic variance-based denoising of
Emanuele and Gurbaxani [9] to use cycle spinning by applying (1)
with T defined by eq. (10) of [9].
We designed and implemented a zero-phase, finite-impulse
response (FIR) filter for LibSELDI (LS) to prepare processed
spectra for quantification using peak heights or peak areas. While
LS has been shown previously to perform well at resolving the
mean m/z of peak clusters in a group of spectra, the denoised
output of the modified Antoniadis-Sapatinas algorithm often
decreases the peak heights. This effect was noted previously by
Besbeas et al. [10]. The comparison paper by Cruz-Marcelo et al.
[11] showed that different preprocessing techniques tend to be
good at peak detection and peak quantification, respectively. This
seems to imply that separate strategies are required for these
preprocessing tasks. We designed the filter using the Parks-
McLellan algorithm to give us good noise attenuation properties
while maintaining the fidelity of the peak shape [12].
To automate peak validation, a feed-forward neural network
with one hidden layer and sigmoid activation function was built in
4 steps: 1) a large set of manually validated peaks to use for model
parameter estimation was created, 2) peaks were divided into
Wavelet/Neural Network Algorithm for SELDI
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training/validation/test sets according to a 50/25/25 percent
split, 3) model parameters were estimated,
H~ H(1)[<n|n2 ,H(2)[<n2|1
 
, and regularization parameter, l,
using the training and validation sets, and 4) the generalization/
test error was estimated. A detailed review of neural networks can
be found in [13]. In our model of peak validation, a peak had one
of two states: y~1 if validated and y~0 if discarded. The goal of
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Note that in (2)–(4), f
(i)
k represents the k
th element of the n
dimensional feature vector f(i). For a given l, Jl Hð Þ was
minimized using the conjugate-gradient method (Polack-Ribiere)
with step sizes selected by the slope-ratio method and Wolfe-
Powell stopping criteria [14]. To fit the regularization parameter,
we calculated the validation set classification error over a grid of l
values and kept the H corresponding tos the l giving the lowest
validation set classification error. With this best set of parameters,
we evaluated the performance on the test set to estimate the
expected performance on data that the neural network has not
seen. Using the best H, we validated a predicted peak cluster from
a clinical experiment using the following procedure:
1. Let x(1), . . . ,x(m)
 
and s(1), . . . ,s(m)
 
be a collection of raw
and accompanying processed spectra, respectively, from LS.
Define mz to be a mean peak cluster m/z value estimated to be
present in the data using LS.
2. In a local window +0:3% around mz, find if a local peak, mzi
exists. If so, extract feature vector f(i) from x(i),s(i),mzi
 
, and
add i to set f. Repeat for all spectra i~1, . . . ,m.
3. For i[f, ‘‘look’’ at the peak with the neural network to validate
the prediction. In other words, keep peak i in the cluster if and




4. Calculate the peak cluster prevalence as
DfD
m
, and extract peak
height and peak area values for each peak that has been
validated for use in the group analysis step later.
We used a dataset of spectra from 31 pooled cervical mucous
QC samples to evaluate the ability of LS and CE to accurately find
peak cluster mean m/z values corresponding to reproducible
peaks. We define a reproducible peak as one that is present at the
same m/z value (within 0.3% mass error tolerance) in 80% or
more of the spectra. Two of the authors (VE, GP) visually
inspected every reproducible peak predicted by each method
adhering to the following protocol:
1. Size of window or zoom was 62% of the m/z value of the
peak.
2. Peaks were categorized separately as Confirmed or Rejected
for the processed and raw spectra. Agreement was required
between authors VE and GP for close calls.
3. If a peak was confirmed in the processed spectra but rejected in
the raw spectra, the final consensus call was ‘‘reject’’, as the
peak could be an artifact introduced after processing.
4. Criteria for rejection were:
a. Peaks that were too broad at a given m/z.
b. Peaks that could not be distinguished from the noise of the
surrounding regions.
c. A cluster is rejected if there were less than 24 spectra with
good peaks (prevalence = 24/30 = 80%).
d. Peak was clearly an artifact from the preprocessing step.
Once all reproducible peaks had a final annotation of
confirmed or rejected, summary statistics were calculated to
analyze the virtues of each approach. For each approach, we
calculated.
Sensitivity TPRð Þ~ TP
FNzTP




In this case, the estimated TP is the number of reproducible
peaks predicted that were confirmed by visual inspection, the
estimated FN is the number of confirmed peaks that were missed,
and the estimated FP is the number of peaks that were rejected as
false after visual inspection. In other words, sensitivity is the
percentage of reproducible peaks that are confirmed via manual
validation, while the false discovery rate is the percentage of
reproducible peaks that were rejected after manual validation but
predicted by CE or LS.
We tested both CE and LS on a pilot clinical data set containing
16 controls and 8 cases. In addition to estimating mean peak
cluster m/z values accurately, clinical data presents the additional
challenge of accurately estimating peak cluster prevalence and
peak height/area measurements. Fisher-exact tests with mid-P
correction were used to test for significant prevalence differences
between cases and controls. T-tests and Mann-Whitney U tests
were performed to find peak clusters with significant differences.
Peak clusters with statistically significant behavior were qualitative
reviewed to check for quality of the preprocessing and neural
network-based validation results.
ð2Þ
Wavelet/Neural Network Algorithm for SELDI
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Results
All samples were tested in duplicate and provided spectral
profiles in the initial run. In the case of 3 samples, duplicate
spectra were removed after initial analysis using CE as the
normalization factor (NormF) was greater than average
NormF+2s generated with the batch analysis. These samples
were rerun and replicate spectra used in further analysis. In the
case of LS analysis, duplicate or replicate spectra were averaged to
produce a single spectrum representing each subject prior to peak
detection, unlike CE. In the CE analysis, duplicates or replicates
peak heights were averaged after peak detection but before t-tests/
group analysis.
We estimated the quadratic variance function (QVF) from
spaces between the peaks of the QC data. Peak-free regions were
selected by visual inspection, with the mean and variance at each
point calculated across spectra. A quadratic detector response
curve is fit to the mean/variance points using least squares, and
results of the QVF estimation procedure are shown in Figure 1.
The QVF is stored for use with LS as part of the modified
Antoniadis-Sapatinas (mA-S) algorithm for denoising the QC and
clinical spectra.
Extending the modified Antoniadis-Sapatinas algorithm to use
cycle spinning required decreasing the computational complexity
of the algorithm. For the implementation of the mA-S algorithm
used in [9,10], approximately 19.5 minutes of computing time
using 10Gb of RAM was required to denoise a single spectrum.
Coifman and Donoho showed that it is sufficient to compute
O log nð Þ shifted transforms for a signal of length n. In a typical
low-laser low-mass focused spectrum we have generated,
O log nð Þ&15, which means it would take almost 5 hours for a
cycle-spinning mA-S algorithm to denoise a single spectrum. Five
hours is enough time to manually process several spectra, so this
result is unacceptable. We made the following observations about
the computations:
1. The slow part of the computation was the default implemen-
tation for calculating the term Wð ÞV xð Þ from Eq. (9) of [9].
2. Many computations were redundant in the 2-D wavelet
decomposition used to calculate this term; i.e. the wavelet
operator was the same for every spectrum and does not need to
be recomputed every time.
3. The n 6 n wavelet operator was very sparse, containing
approximately 99% zeros.
Combining these facts we implemented a sparse matrix-based
formulation of the problem to save memory and computation time
rather than the standard 2-D filter bank decomposition. The
wavelet transform matrix was constructed one time and a sparse-
format matrix is stored off line. The sparse-matrix representation
uses significantly less memory. Thus, in this implementation,
every-time the Wð ÞV xð Þ component needs to be computed, a
sparse-matrix computed offline is read into memory and
computation performed with a simple matrix multiply. This
implementation resulted in a 6406 speed up, as illustrated in
Table 1. The time required to denoise a dataset of spectra from a
group of 60 spectra decreased from ,16 hours to less than
1.5 minutes.
The FIR low-pass filter coefficients were estimated using the
Parks-McClellan algorithm in MATLAB (firpm and firpmord
functions). The specifications given the algorithm are: normalized
frequency transition band between 0.15 and 0.25, pass-band ripple
of 0.01, and stop band attenuation of 60 decibels (dB). The non-
causal zero-phase implementation of the filter is used to prevent
phase delays and preserve the locations of the peaks (filtfilt
command in MATLAB)[15]. The order of the filter is 67. In
Figures 2 and 3, we show the frequency response of the filter and
Figure 1. Quadratic detector response curve fit to data using space between the peaks of QC spectra.
doi:10.1371/journal.pone.0048103.g001
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smoothed output, respectively. Our FIR filter can be thought of as
an extension of a Savitsky-Golay filter with greater noise
suppression properties at high frequencies [16]. The smoothed
spectra are much more visually consistent with that expected from
visual observation by clinicians. The FIR smoothing procedure
gives rise to , 700 local maxima compared to the , 150 given by
the A-S algorithm, illustrating the tradeoff between peak detection
performance and denoising performance between different
smoothing approaches.
A feed-forward artificial neural network with one hidden layer
was designed that validates peaks with (96.5%, 93.4%, 94.7%)
accuracy on the training set, validation set, and test set,
respectively. Peaks were detected in the QC data using LS with
the most liberal settings possible so as to cast a wide net for all
possible peak configurations and shapes in the data for the training
process. We manually validated each prediction as a confirmed
peak, a noisy/false prediction, or indeterminate. All indeterminate
predictions were removed from the model estimation process.
After removal of indeterminate cases, we had 4256 expert-
annotated predictions, containing 57.07% percent ‘‘true’’ (con-
firmed peak) examples. We then randomly sampled the data into
an approximate 50/25/25% split for the training set, validation
set, and test set respectively. To construct the corresponding 62-
dimensional feature vector f(i) corresponding to a peak predicted
at mass mzi, we considered the following intuition about how we
manually QC peaks in-house.
1. For SELDI, all the information needed to make a judgment
about peak validity is contained in a window mzi+0:3%.
2. When deciding whether a peak is acceptable or not, both the
raw and processed spectra carry important information; a good
peak shape in the processed spectra is not sufficient by itself if
the corresponding raw spectrum is very noisy and of poor
quality.
3. mzi may affect judgment due to changes in the theoretical peak
shape as a function of mass.
4. Good peaks seem to look like a healthy concave quadratic
centered at mzi, but not always.
These insights are applied to the following procedure used to
construct the feature vector. Let Mi~ mi,1, . . . ,mi,30ð Þ be a linear
grid of 30 m/z points evenly spaced over the inter-




:Dmz.(peak concavity measure, with parameter a
representing the quadratic coefficient of the best fit quadric
curve for the raw intensities in the window centered at mzi).
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32 = the linearly interpolated intensities of the
processed spectrum on support Mi.
4. f
(i)
33, . . . ,f
(i)
62 = the linearly interpolated intensities of the raw
spectrum on support Mi.
We used a fully-connected feed-forward neural network with 63
input nodes, 21 hidden layer nodes, and 1 output layer node
(including bias nodes). Thus, the parameter matrices had
dimensions H(1)[<63|20,H(2)[<21. Before training, all features
were standardized by subtracting the mean value in that
dimension and dividing by the standard deviation (calculated
across the training set). The normalization parameters are saved
for use with the neural net on the validation data, test data, and
clinical data. Regularization was used to control the complexity
and avoid over-fitting. For each candidate value of l across a grid
of points L (between 0.003 and 10), the best-fit H~ H(1),H(2)
 
neural network parameters were found by using conjugate-
gradient descent to minimize Jl Hð Þ across the training set. The
gradient of Jl Hð Þ was calculated using the forward/back-
propagation algorithm [13]. The optimization step was observed
to converge after 400 iterations. For each l, we calculated the
classification error on the validation set, err
(val)
l . We selected our
optimal neural network parameters as
Table 1. Processing time (in seconds) for denoising a single spectrum using different implementations of the modified Antoniadis-
Sapatinas algorithm.
n
Implementation 210 211 212 213 214 215
Original 0.1235s 0.5066s 2.0476s 7.8817s 32.5274s 1155.85s
Gen-Sparse 0.0688s 0.2392s 0.9250s 9.1161s 23.3283s 97.5260s
Offline-Sparse 0.0089s 00174s 0.0407s 0.0999s 0.2177s 1.7856s
doi:10.1371/journal.pone.0048103.t001
Figure 2. 67th order FIR filter frequency response designed for
flat-pass band analogous to a Savitsky-Golay filter, but with
better high-frequency noise suppression properties.
doi:10.1371/journal.pone.0048103.g002
Wavelet/Neural Network Algorithm for SELDI












where, in Eq. (6) it is understood that the estimate of H is most
likely only a local minima. The trained neural network hH was
evaluated on the independent test set and found to perform with a
classification accuracy of 94.7%. By design, the test set was not
used at any stage of the parameter-fitting process in order to
ensure our test set classification accuracy estimate is an unbiased
estimate for how the neural network will perform on peaks it has
not ‘‘seen’’ at any stage of parameter fitting.
LibSELDI showed improved sensitivity and specificity for
detecting peak cluster mean m/z values corresponding to
reproducible peaks in the pooled-sample QC data. Figure 4 shows
the operating characteristics for LS at each iteration of improve-
ment discussed in the Methods section. On QC spectra, LS
recovered ,50% percent of the true peak cluster m/z values
without a mistake, and 70% at a 5% FDR. Operating points for
Ciphergen Express using stringent (S/N 3/2) and non-stringent
parameter settings (S/N 1) show a reference method for
comparison. While peak cluster mean m/z values were recon-
structed successfully, this benchmark did not show the accuracy of
individual peak predictions within a cluster, a limitation of this
approach. Resolving individual peak predictions within a cluster is
critical for clinical group analysis and is discussed next.
LS w/neural network validation found 124 peak clusters and
resolved peak predictions accurately within clusters and CE with a
SOP were applied to the pilot clinical mucous data. An overview
of the LS/neural network strategy for analyzing clinical data is
shown in Figure 5. Since the LS/neural network predictions were
able to resolve more accurate peak predictions within clusters, this
set the stage for a variety of analyses that would have been more
difficult to carry out with Ciphergen Express alone. The results of
t-tests, Mann-Whitney U-tests, and Fisher-exact tests with mid-P
correction are shown in Tables 2 and 3. Only 2 p-values come in
less than 0.01, and each test conducted tells a different story.
There is some consistency in the tests with regards to which peak
clusters tend to ‘‘look’’ different with respect to the various tests.
With the different parameters used for peak detection, CE
detected 106 (stringent) and 168 (non-stringent) peak clusters.
Under the stringent parameter (S/N 5/3), 6 peak clusters were
found to have differences (p-values less than 0.05, no multiple test
correction) (Table 4) based on peak heights between CIN0 and
CIN3 groups as opposed to 10 peak clusters with less stringent
parameter (S/N 3/2). However, in several cases visual inspection
of the spectra showed that peak detection was not accurate thereby
leading to false readings of peak heights, as shown in Figure 6.
This could be attributed to the need to include ‘estimated peaks’ as
a peak detection parameter to enable calculation of p-values
between sample groups in CE.
Discussion
Neural networks were successful in their ability to automate the
manual/visual validation step, mimicking the peak-calling perfor-
mance of our in-house scientists with somewhere between 93%–
95% accuracy. While this is very good classification performance
for a complex task, we feel that for a true revolution to take place
in SELDI preprocessing automation we would require a classifier
with classification accuracies greater than 99.9%. After all, at our
current accuracy rates, we still expect the neural-network validator
to make 1–2 validation mistakes per cluster on our data. We feel
strongly that if we could increase our training data by an order of
Figure 3. An example denoised peak using the FIR filter approach used for quantification. This is a typical example where the Antoniadis-
Sapatinas denoising would find the peak but distort its peak height.
doi:10.1371/journal.pone.0048103.g003
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magnitude (from ,5000 peak examples to ,50,000), the neural
network approach we outlined could achieve such accuracy. With
a classification accuracy of 99.9% we would only expect to make a
single mistake validating a peak cluster representing a sample size
of 1000! Such performance would enable the design of large
studies with greater statistical power for making a biological
discovery.
A case study in the challenges arising in biomarker discovery is
the proteomics literature studying breast cancer. Starting in
approximately 2002, breast cancer studies began to appear using
the SELDI platform. Over the next several years, many studies
followed using different specimens (mostly serum, plasma, or
nipple aspirate fluid or NAF), on different groups of patients (early
stage breast cancer, post-operative, benign breast cancer, those
undergoing surgery, chemotherapy, radiation treatment, or some
combination of the above), and some using the closely related
MALDI instead of SELDI. Several proteins of interest began to
emerge from the studies as being reproducible. Two helpful
reviews by Calleson [17] and Gast [18] compiled some of the
results. Specifically, three peaks of interest occurred in $5 studies
that were subsequently identified via more specific protein
chemistry methods: a neutrophil associated protein at ,3440
Da, the inter-alpha-trypsin inhibitor heavy chain H4 (ITIH4) at
,4300 Da, and the complement protein C3a des-arginine
anaphylatoxin at , 8940 Da. In all 3 cases, although multiple
studies verified both the magnitude (reported as a p-value ,0.05)
and direction (over or under expressed in cancer) of the reported
differences between groups, at least one confirmatory study using
the same type of sample from similar groups of study subjects
could not verify the magnitude of the difference, i.e. the p-value
was no longer significant, or even the direction, i.e. the peak went
from being significantly over expressed in cancer to significantly
under expressed or vice versa [19–21]! The authors of these
reviews and confirmatory studies therefore had to conclude in
each case that more work was needed. Further preprocessing
technique improvements enabling larger studies could help
prevent some of the issues encountered by these studies.
Through a series of advancements to the different parts of the
processing pipeline, LibSELDI has shown great promise for a level
of detail in analysis of clinical data that was previously unavailable.
The combination of the Antoniadis-Sapatinas algorithm-based
denoising with an FIR filter designed for better noise suppression
properties than popular Savitsky-Golay filter was a good
combination of the strengths of each approach. The A–S
algorithm has shown good performance for detecting and
estimating peak cluster mean m/z values on simulated, pooled-
sample QC, and clinical data. The tendency of the A–S denoising
approach to unsatisfactorily alter the peak heights in the denoised
spectra is balanced carefully with the FIR-filter based quantifica-
tion step. We illustrated that the FIR-filtering step on its own
would produce too many peak predictions, leading to many false
positive peak clusters. By gluing these two methods together we
have been able to capitalize on their respective strengths. We have
confirmed that SELDI spectra are too inherently bumpy for a
single denoising method to be superior at both the peak detection
and quantification steps.
The computational tricks that enabled inclusion of the cycle-
spinning variant of the modified A–S algorithm were also
important, bringing LS a step closer towards enabling the use of
SELDI for study designs with large sample size. We showed that a
dataset that used to take 16 hours to process can now be processed
in under 1.5 minutes. The addition of cycle-spinning reduced the
energy in wavelet artifacts present in the denoised spectra, which
Figure 4. False-discovery rate and true-positive rate operating points showing various stages of improvement for LibSELDI.
doi:10.1371/journal.pone.0048103.g004
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led to increased sensitivity and specificity of the algorithm when
benchmarked on the pooled-sample QC data.
The LibSELDI/neural-network validated peak clusters gave us
higher quality predictions, allowing us to resolve individual peak
predictions within clusters to a degree of accuracy that gave us
fairly accurate measurements of the peak prevalence in each
cluster and with respect to the case/control labels in the study. We
were able to carry out a series of both parametric and non-
parametric analyses based on peak height, peak area, and peak
cluster prevalence. These analyses would have been impractical to
conduct using the Ciphergen Express software alone. In all, 11
unique clusters came out of the analysis at a significance level
Figure 5. LibSELDI/neural network strategy for analyzing clinical spectra.
doi:10.1371/journal.pone.0048103.g005
Table 2. CIN0 vs. CIN3 group tests (t-tests and Mann-Whitney U-tests) based on peak height and peak area measurements.









16054.5 Da 180 (8.6) 150 (1.1) 11821.9 Da 0.69 (0.12) 0.27 (0.07) 6912.8 Da 52.1 (0.6) 58.2 (3) 11821.9 Da 0.69 (0.1) 0.27 (0.1)
3017.1 Da 26.5 (1.6) 21.9 (0.6) 16054.5 Da 0.58 (0.09) 0.26 (0.003) 12680.8 Da 116.8 (3.8) 136.5 (8.0) 8287.7 Da 0.15 (0.03) 0.07 (0.008)
8287.7 Da 66.6 (0.9) 64.0 (0.4) 3017.1 Da 0.48 (0.12) 0.13 (0.03) 10427.1 Da 83.3 (1.9) 88.5 (2.8) 3682.3 Da 0.46 (0.06) 0.89 (0.16)
11821.9 Da 115.6 (5.1) 100.4 (3.8) 3682.3 Da 0.46 (0.06) 0.89 (0.16) 3682.3 Da 34.2 (1) 40.3 (2.3) 12680.8 Da 0.38 (0.07) 0.78 (0.15)
2887.8 Da 24.6 (0.5) 22.6 (0.6) 2887.8 Da 0.32 (0.04) 0.18 (0.03) 5647.0 Da 45.2 (0.6) 42.7 (0.8) 6912.8 Da 0.13 (0.01) 0.38 (0.13)
5849.7 Da 49.7 (2.2) 43.1 (1.0) 8287.7 Da 0.15 (0.03) 0.07 (0.01)
3682.3 Da 34.2 (1.0) 40.3 (2.3) 5647.0 Da 0.22 (0.02) 0.14 (0.02)
12680.8 Da 0.38 (0.07) 0.78 (0.15)
Showing quantification (SEM) for clusters with p-values less than 0.05.
doi:10.1371/journal.pone.0048103.t002
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below 0.05. Performing the study and analysis on a clinical set with
larger sample size is a future work.
The current study contains several limitations that should be
noted when interpreting the results. First, we have only shown
results on a single sample medium analyzed on a single chip type.
While we feel that LibSELDI algorithm extensions and neural-
network validation model will extend to other Protein Chips and
sample types (e.g. serum, plasma), we have not shown that in this
paper. Also, the extension of the neural network to other chip and
sample types may require adding significant additional training
data to tune the neural network. In general, the baseline removal
process has an effect on the quantification of peak heights and
peak areas. To the authors’ knowledge, there has been no study to
date isolating the effect of baseline removal on peak quantitation.
This holds for true for LS that we do not have a thorough
understanding of the effect of the baseline removal technique used.
Lastly, the sample size in our pilot clinical sample is too small to
make any real biological conclusions. The small sample size was
convenient for performing a preliminary evaluation of the LS and
CE methodology on real clinical data. Follow up studies with
larger samples sizes will be necessary in order to understand the
Table 3. CIN0 vs. CIN3 prevalence differences scored using










3017.1 Da 0.375 0.938 0.007
Showing only clusters with p-values less than 0.05.
doi:10.1371/journal.pone.0048103.t003
Figure 6. An example peak cluster output from Ciphergen Express v3.5.
doi:10.1371/journal.pone.0048103.g006
Table 4. CIN0 vs. CIN3 group tests (Mann-Whitney) based on
peak height measurements under stringent condition (S/N 5/
3) using Ciphergen Express.
Cluster
—
mz Average Peak Height (SD)
CIN3 CIN0
21663.4 0.843 (0.44) 0.429 (0.41)
3904.4 5.442 (7.75) 12.201(10.72)
7910.3 1.676 (1.36) 6.00 (5.63)
17205.5 0.121 (0.13) 0.570 (0.55)
8378.3 0.747 (0.35) 1.571 (1.26)
17341.8 0.171 (0.21) 0.57 (0.60)
Showing only clusters with p-values less than 0.05.
doi:10.1371/journal.pone.0048103.t004
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performance limits of the methodology and to assess potential
increases in statistical power for making biological discovery.
Lastly, while we have qualitatively observed an improvement in
the characterization of peak prevalence for peak clusters in clinical
data, there is considerable room in the literature for a future work
quantifying the performance of peak cluster composition/preva-
lence estimation.
The algorithmic and computational improvements in Lib-
SELDI combined with the neural network-based peak cluster
validation model moves us one step closer to larger SELDI
experiments with greater chance of reproducible biological
discovery.
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